Login / Signup

Tazarotene 0.045% Lotion: A Novel Retinoid Formulation.

Lindsey A MohneyRohan SinghSteven R Feldman
Published in: The Annals of pharmacotherapy (2022)
Tazarotene 0.045% lotion is an effective and well-tolerated retinoid recently approved by the US Food and Drug Administration (FDA) for treating acne vulgaris in individuals 9 years of age and older.
Keyphrases
  • drug administration
  • drug delivery
  • community dwelling
  • physical activity
  • middle aged
  • hidradenitis suppurativa
  • human health
  • risk assessment